TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design
- URL: http://arxiv.org/abs/2310.03223v5
- Date: Sun, 7 Apr 2024 17:16:22 GMT
- Title: TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design
- Authors: Tony Shen, Seonghwan Seo, Grayson Lee, Mohit Pandey, Jason R Smith, Artem Cherkasov, Woo Youn Kim, Martin Ester,
- Abstract summary: Molecular deep generative models have been introduced which promise to be more efficient than exhaustive virtual screening.
We propose TacoGFN, a Generative Flow Network conditioned on protein pocket structure, using binding affinity, drug-likeliness and synthesizability measures as our reward.
- Score: 3.45184803671951
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Searching the vast chemical space for drug-like and synthesizable molecules with high binding affinity to a protein pocket is a challenging task in drug discovery. Recently, molecular deep generative models have been introduced which promise to be more efficient than exhaustive virtual screening, by directly generating molecules based on the protein structure. However, since they learn the distribution of a limited protein-ligand complex dataset, the existing methods struggle with generating novel molecules with significant property improvements. In this paper, we frame the generation task as a Reinforcement Learning task, where the goal is to search the wider chemical space for molecules with desirable properties as opposed to fitting a training data distribution. More specifically, we propose TacoGFN, a Generative Flow Network conditioned on protein pocket structure, using binding affinity, drug-likeliness and synthesizability measures as our reward. Empirically, our method outperforms state-of-art methods on the CrossDocked2020 benchmark for every molecular property (Vina score, QED, SA), while significantly improving the generation time. TacoGFN achieves $-8.82$ in median docking score and $52.63\%$ in Novel Hit Rate.
Related papers
- Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
We propose a novel and general alignment framework to align pretrained target diffusion models with preferred functional properties, named AliDiff.
AliDiff shifts the target-conditioned chemical distribution towards regions with higher binding affinity and structural rationality, specified by user-defined reward functions.
We show that AliDiff can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score, while maintaining strong molecular properties.
arXiv Detail & Related papers (2024-07-01T06:10:29Z) - Geometric-informed GFlowNets for Structure-Based Drug Design [4.8722087770556906]
We employ Generative Flow Networks (GFlowNets) to explore the vast space of drug-like molecules.
We introduce a novel modification to the GFlowNet framework by incorporating trigonometrically consistent embeddings.
Experiments conducted using CrossDocked 2020 demonstrated an improvement in the binding affinity between generated molecules and protein pockets.
arXiv Detail & Related papers (2024-06-16T09:32:19Z) - PILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling [8.619610909783441]
We propose an in-silico approach for the $textitde novo$ generation of 3D ligand structures using the equivariant diffusion model PILOT.
Its multi-objective-based importance sampling strategy is designed to direct the model towards molecules that exhibit desired characteristics.
We employ PILOT to generate novel metrics for unseen protein pockets from the Kinodata-3D dataset.
arXiv Detail & Related papers (2024-05-23T17:58:28Z) - DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
Existing structured-based drug design methods treat all ligand atoms equally.
We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold.
Our approach achieves state-of-the-art performance in generating high-affinity molecules.
arXiv Detail & Related papers (2024-02-26T05:21:21Z) - Target Specific De Novo Design of Drug Candidate Molecules with Graph
Transformer-based Generative Adversarial Networks [0.0]
We propose DrugGEN, for the de novo design of drug candidate molecules that interact with selected target proteins.
DrugGEN is trained using a large dataset of compounds from ChEMBL and target-specific bioactive molecules.
arXiv Detail & Related papers (2023-02-15T18:59:27Z) - Retrieval-based Controllable Molecule Generation [63.44583084888342]
We propose a new retrieval-based framework for controllable molecule generation.
We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria.
Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
arXiv Detail & Related papers (2022-08-23T17:01:16Z) - Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based
Reinforcement Learning Model [4.815696666006742]
Structure-based de novo method can overcome the data scarcity of active by incorporating drug-target interaction into deep generative architectures.
Here, we demonstrate a widely used and fast protein sequence-based reinforcement learning model for drug discovery.
As a proof of concept, the RL model was utilized to design molecules for four targets.
arXiv Detail & Related papers (2022-08-14T10:41:52Z) - LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique.
Comprehensive experiments show that LIMO performs competitively on benchmark tasks.
One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
arXiv Detail & Related papers (2022-06-17T21:05:58Z) - Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE)
Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor.
We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
arXiv Detail & Related papers (2022-06-06T06:17:11Z) - MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties.
We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
arXiv Detail & Related papers (2020-10-05T20:18:42Z) - CogMol: Target-Specific and Selective Drug Design for COVID-19 Using
Deep Generative Models [74.58583689523999]
We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins.
CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme.
CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
arXiv Detail & Related papers (2020-04-02T18:17:20Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.